BFM
TLSI icon

Boothbay Fund Management’s TriSalus Life Sciences TLSI Stock Holding History

Boothbay Fund Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,980
Closed -$164K – 2287
2023
Q1 		$164K Hold
15,980
– – ﹤0.01% 1799
2022
Q4 		$160K Sell
15,980
-191,367
-92% -$1.92M ﹤0.01% 1671
2022
Q3 		$2.06M Buy
207,347
+189,708
+1,076% +$1.88M 0.05% 560
2022
Q2 		$174K Buy
+17,639
New +$173K ﹤0.01% 1808

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $780M AUM 24.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boothbay Fund Management's TLSI Position: Q2 2023 in Review

Boothbay Fund Management sold out of TriSalus Life Sciences (TLSI) in Q2 2023, closing a stake of 15,980 shares — an estimated $164K sold.

Boothbay Fund Management first reported a position in TLSI in Q2 2022 and held it in 4 quarters. The position peaked at $2.06M in Q3 2022. 6 funds tracked by Wall St. Rank hold TLSI as of Q2 2023.

  • Boothbay Fund Management reported no remaining TriSalus Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 15,980 TriSalus Life Sciences shares in Q2 2023, an estimated $164K.
  • Boothbay Fund Management first reported a position in TriSalus Life Sciences in Q2 2022 and held it in 4 quarters.
  • Boothbay Fund Management's TriSalus Life Sciences position peaked at $2.06M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.